Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;9(3):223-224.
doi: 10.1016/S2213-2600(21)00035-7. Epub 2021 Jan 22.

The right place for IL-1 inhibition in COVID-19

Giulio Cavalli  1 , Lorenzo Dagna  2
Affiliations
Comment

The right place for IL-1 inhibition in COVID-19

Giulio Cavalli et al. Lancet Respir Med. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. - PMC - PubMed
    1. Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. published online July 17. - DOI - PMC - PubMed
    1. Cavalli G, De Luca G, Campochiaro C, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2:e325–e331. - PMC - PubMed
    1. Campochiaro C, Della-Torre E, Cavalli G, et al. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020;76:43–49. - PMC - PubMed
    1. Salvarani C, Dolci G, Massari M, et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial. JAMA Intern Med. 2020;181:24–31. - PMC - PubMed

Publication types

Substances